🧵 What not to miss at the congress
#HeartFailure2023 @escardio
🏆 HERMES
📲 Implementing non-invasive telemedicine services based on mHealth combining teleintervention ➕ telemonitoring in HF-patients with a recent 🏥 admission due to HF decompensation
🎯 is effective in preventing fatal and non-fatal CV events.
🔷 PARAGLIDE ➕PARAGON
Sacubitril/valsartan ⬇️ CV and renal events in HFmrEF and HFpEF.
📁 academic.oup.com/eurheartj/adva…
🔷 Phase 1 trial➡️NI006 had a favorable safety profile in patients with ATTR cardiomyopathy
💊 At doses of at least 10 mg per kg, amyloid-load surrogates appeared to be ⬇️
📁 nej.md/42FG6P6
🔷 ENACT- HF
UNa-guided vs SOC:
⬆️ Natriuresis 🧂
⬆️ Natriuresis 🧂 ➕diuresis 💦
⬇️ length of stay 🏥
🔷 MODA 🇪🇸
Dapagliflozin in chronic HF and optimized therapy results:
🎯 global reverse remodeling of🫀 structure, including LA volumes and improvement in LV geometry
⬇️ NT-proBNP
📁 onlinelibrary.wiley.com/doi/abs/10.100…
🔷 CLOROTIC 🇪🇸
adding oral HCTZ (doses adjusted to eGFR) to IV furosemide:
⬆️ Diuretic response in AHF 💦
🧩 Independent of initial eGFR
⬆️ Response in patients with better baseline renal function💦
🔷 Effect of iv iron replacement
on recurrent HF🏥 and CV ☠️ in HF and iron deficiency 🔩
FAIR-HF➕CONFIRM-HF➕
AFFIRM-AHF
⬇️in recurrent HF 🏥 and CV mortality.
🧩Results were nominally consistent across the subgroups studied
📁 onlinelibrary.wiley.com/doi/10.1002/ej…
🔷 STEP-HFpEF programm
➡️ is testing semaglutide effects on symptoms, physical limitations & exercise function in obesity HFpEF phenotype.
📁 jacc.org/doi/10.1016/j.…
🔷 Slides 🔝
In- 🏥 Initiation of HF therapies @ShelleyZieroth
🔔 HF Guidelines: new evidence in 2023 (not available in 2021) by Piotr Ponikowski
❤️ And of course, the reunion with great friends‼️
See you in Lisbon 🇵🇹
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.